A case of insulinoma misidentified as schizophrenia due to its manifestation in neuropsychiatric symptoms Tomoyuki HabaKengo YamakawaDaisuke Yabe Case Report 21 April 2024
Immune checkpoint inhibitor-related type 1 diabetes mellitus which develops long after treatment discontinuation: a case report and review of literature Yoshinari ObataMiho TakemotoIichiro Shimomura Case Report 18 April 2024
A case of congenital hyperinsulinism presenting with diabetes after long-term diazoxide therapy Miwa FuruzonoMika MakimuraKenichi Miyako Case Report 16 April 2024
Patients with diabetes and obesity exhibit characteristics in eating and coping behaviors and personality traits Masahiro SaitoIsao UsuiYoshimasa Aso Original Article 16 April 2024
Uric acid is associated with type 2 diabetes: data mining approaches Amin MansooriDavoud TanbakuchiMajid Ghayour-Mobarhan Original Article 16 April 2024
Glycemic control of once-weekly and other administration frequencies for DPP-4 inhibitor in patients with type 2 diabetes: a real-world retrospective cohort study Ruriko KotoShiori YoshidaRimei Nishimura Short Communication 13 April 2024
Influence of the COVID-19 pandemic on the achievement of guideline targets for HbA1c, blood pressure, and LDL cholesterol in people with diabetes in Japan Shingo KuwajimaTakahito ItohTakayuki Miki Original Article 08 April 2024
Identification of herbal drug extracts that promote growth of Akkermansia muciniphila in high-fat diet fed mice Shiho FujisakaYoshiyuki WatanabeKazuyuki Tobe Original Article 06 April 2024
Comparison of medication persistence and adherence in type 2 diabetes using a once-weekly regimen of DPP-4 inhibitor compared with once-daily and twice-daily regimens: a retrospective cohort study of Japanese health insurance claims data Tetsuya MiwaShiori YoshidaRimei Nishimura Original Article 03 April 2024
Effects of dulaglutide and trelagliptin on beta-cell function in patients with type 2 diabetes: a randomized controlled study: DUET-beta study Yoshinobu KondoShinobu SatohYasuo Terauchi Original Article 03 April 2024
Frequency and determinants of lipid management target achievement in primary prevention of cardiovascular disease in type 2 diabetes Aika MiyaAkinobu NakamuraTatsuya Atsumi Original Article 02 April 2024
Impact of health practice index and cardiovascular health metrics on incident cardiovascular disease according to glucose tolerance status Koshiro MuraiKazuya FujiharaHirohito Sone Original Article 02 April 2024
A case of diabetic ketoacidosis with prurigo pigmentosa as a dermadrome Sachiko HiraokaMuneo Kawasumi Case Report 01 April 2024
A sensor-augmented pump with a predictive low-glucose suspend system could lead to an optimal time in target range during pregnancy in Japanese women with type 1 diabetes Rie Kaneshima TamuraNoriko KodaniHiroshi Itoh Original Article 30 March 2024
The relationship between DASC-8 categories and the effectiveness of education on insulin self-injection techniques in elderly patients with diabetes Taisuke UchidaHiroaki UenoKazuya Shimoda Original Article 29 March 2024
Advances in the clinical measurement of glucagon: from diagnosis to therapy Tadahiro KitamuraMasaki Kobayashi Mini-Review 27 March 2024
Impact of early-morning administration of rapid-acting insulin on the increase in blood glucose levels related to the dawn phenomenon in individuals with type 1 diabetes Tomofumi TakayoshiYushi HirotaWataru Ogawa Original Article 25 March 2024
Pregnancy-associated fulminant type 1 diabetes: a case report and review of the literature Hikari NebashiHitoshi MatsuiHiroko Takanashi Case Report 12 March 2024
Association between erectile dysfunction and subjective well-being in primary care patients with type 2 diabetes Hazem A. Sayed AhmedEhaab Mahmoud AbdallahAhmed Mahmoud Fouad Original Article 12 March 2024
A case of rapidly progressive insulin-dependent diabetes mellitus without islet autoantibodies developed over two years after the first dose of nivolumab Kota NishihamaYuko OkanoYutaka Yano Case Report 11 March 2024
Correction: New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version) Akira ShimadaEiji KawasakiHiroshi Ikegami Correction 07 March 2024
Type 1 diabetes mellitus following COVID-19 vaccination: a report of two cases and review of literature Shota MochizukiJunnosuke MiuraTetsuya Babazono Case Report 29 February 2024
Impact of inpatient management of hyperglycemia on peripheral T cell markers in patients with type 2 diabetes Tomohisa KuniiIsao UsuiYoshimasa Aso Original Article 26 February 2024
Advances in basic research on glucagon and alpha cells Yoshitaka Hayashi Mini-Review 26 February 2024
Incidence of overt diabetes in pregnancy among women with 50-g glucose challenge test ≥ 200 mg/dL Dittakarn BoriboonhirunsarnAmporn RobkhonburiDawrueng Gusonkhum Original Article 24 February 2024
Current status of screening and management of gestational diabetes in early pregnancy: a questionnaire survey in Japan Maki YokoyamaKei MiyakoshiTakashi Sugiyama Short Communication 20 February 2024
Predictors of the effectiveness of isCGM usage in adults with type 1 diabetes mellitus: post-hoc analysis of the ISCHIA study The ISCHIA Study GroupTakashi MurataMasao Toyoda Original Article 15 February 2024
Exosomal UMOD gene expression and urinary uromodulin level as early noninvasive diagnostic biomarkers for diabetic nephropathy in type 2 diabetic patients Shaimaa I. BarrSahar S. BessaEman M. Abd El-Azeem Original Article 12 February 2024
Changes in serum levels of liver-related parameters, uric acid, and hemoglobin in patients with type 2 diabetes mellitus under treatment with tofogliflozin—a post-hoc analysis of the UTOPIA study Naoto KatakamiTomoya MitaIichiro Shimomura Original Article 10 February 2024
Effects of simultaneous pancreas and kidney transplantation in Japanese individuals with type 1 diabetes and end-stage kidney disease Tomomi MoriIzumi NyumuraTetsuya Babazono Original Article 24 January 2024 Pages: 278 - 289
Associations of ALT/AST, a marker of hepatosteatosis, with pulse rate in young women and with blood pressure in middle-aged women independently of abdominal fat accumulation and insulin resistance Satomi Minato-InokawaAyaka Tsuboi-KajiKeisuke Fukuo Original Article 24 January 2024 Pages: 270 - 277
Mortality in childhood-onset type 1 diabetes mellitus with onset between 1959 and 1996: A population-based study in Hokkaido, Japan Nobuo MatsuuraHiroshi Yokomichion behalf of the Study Group of Long-term Prognosis of Type 1 Diabetes in Hokkaido, Japan Original Article 24 January 2024 Pages: 262 - 269
Impacts of “Diabetes Theater,” a participative educational workshop for health care professionals, on participants: a patient empowerment perspective Ryotaro AbeKentaro OkazakiMasafumi Kuzuya Short Communication 23 January 2024 Pages: 307 - 312
Predictive patterns of lower urinary tract symptoms and bacteriuria in adults with type 2 diabetes Keiji SugaiJunko SasakiMasato Odawara Original Article 23 January 2024 Pages: 253 - 261
Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10) Hideki KamiyaTatsuhito HimenoJiro Nakamura Report of the Committee 12 January 2024 Pages: 19 - 27
Glycemic control and dementia risk in patients aged above and below 75 years Hae Hyuk Jung Original Article 08 January 2024 Pages: 244 - 252
Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes Junko OyaTomoko NakagamiTetsuya Babazono Original Article 08 January 2024 Pages: 237 - 243
Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists—secondary publication Atsushi GotoKen OhashiHirotaka Watada Report of the Committee 08 January 2024 Pages: 5 - 18
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version) Akira ShimadaEiji KawasakiHiroshi Ikegami Report of the Committee 08 January 2024 Pages: 1 - 4
Two patients with α-chain hemoglobin variant Hb Q-Iran detected by measuring hemoglobin A1c using the variant mode of the HA-8180V HPLC analyzer Maki KinoshitaDaiki ShimomuraMasafumi Koga Short Communication 06 January 2024 Pages: 302 - 306
Biomarkers and signaling pathways of diabetic nephropathy and peripheral neuropathy: possible therapeutic intervention of rutin and quercetin Tamsheel Fatima RoohiSeema MehdiSyed Faizan Review Article 19 December 2023 Pages: 145 - 169
Correction: Patients with gestational diabetes mellitus may be treated in both early and late pregnancy, especially in patients with pre-pregnancy overweight: A cross-sectional study in Japan Ayaka TakemotoYoshio NagaiMasakatsu Sone Correction 18 December 2023 Pages: 313 - 313
Exploring mechanisms underlying diabetes comorbidities and strategies to prevent vascular complications Takayoshi Sasako Review Article 18 December 2023 Pages: 34 - 40
Adipose Tissue Plasticity and Insulin Signaling in the Pathogenesis of Type 2 Diabetes Masaji Sakaguchi Review Article 18 December 2023 Pages: 28 - 33
Gender differential in the pattern and severity of perceived symptoms among diabetes patients in India Shubham RanjanRamna Thakur Original Article 16 December 2023 Pages: 223 - 236
Correction: Trends in clinical characteristics and factors associated with initial prescription of SGLT2 inhibitors in Japanese patients with type 2 diabetes mellitus Hiroshi TakahashiYuka SuganumaRimei Nishimura Correction 12 December 2023 Pages: 141 - 141
Rapid improvement of severe fatty liver in a case of fulminant type 1 diabetes following insulin treatment Sonomi NodaNozomi HaraiKyoichiro Tsuchiya Case Report 11 December 2023 Pages: 297 - 301
